Western Wealth Management, LLC Abb Vie Inc. Transaction History

Western Wealth Management, LLC

$1.72 Billion
Q3 2024

A detailed history of Western Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Western Wealth Management, LLC holds 36,096 shares of ABBV stock, worth $6.34 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

36,096

Previous 20,797 73.56%

Holding current value

$6.34 Million

Previous $3.57 Million 99.83%

% of portfolio

0.41%

Previous 0.27%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $2.51 Million - $3.05 Million	15,299 Added 73.56%	36,096 $7.13 Million
Q2 2024 Jul 19, 2024	BUY	$154.79 - $180.76 $83,431 - $97,429	539 Added 2.66%	20,797 $3.57 Million
Q1 2024 May 02, 2024	SELL	$159.82 - $182.1 $2.41 Million - $2.74 Million	-15,061 Reduced 42.64%	20,258 $3.69 Million
Q4 2023 Jan 31, 2024	SELL	$137.6 - $154.97 $275,475 - $310,249	-2,002 Reduced 5.36%	35,319 $5.47 Million
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $143,609 - $166,248	1,075 Added 2.97%	37,321 $5.56 Million
Q2 2023 Aug 30, 2023	SELL	$132.51 - $164.9 $226,062 - $281,319	-1,706 Reduced 4.5%	36,246 $4.88 Million
Q1 2023 Aug 30, 2023	BUY	$144.61 - $166.54 $652,046 - $750,928	4,509 Added 13.48%	37,952 $6.05 Million
Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $3.02 Million - $3.62 Million	-21,821 Reduced 39.49%	33,443 $5.41 Million
Q3 2022 Nov 04, 2022	SELL	$134.21 - $153.93 $33,015 - $37,866	-246 Reduced 0.44%	55,264 $7.6 Million
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $154,684 - $196,655	-1,124 Reduced 1.98%	55,510 $8.5 Million
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $4.43 Million - $5.5 Million	33,597 Added 145.84%	56,634 $9.18 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $659,083 - $833,930	-6,135 Reduced 21.03%	23,037 $3.12 Million
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $1.18 Million - $1.32 Million	11,255 Added 62.82%	29,172 $3.29 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $68,745 - $75,680	672 Added 3.9%	17,917 $1.94 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $28,895 - $39,012	-359 Reduced 2.04%	17,245 $1.85 Million
Q3 2020 Oct 27, 2020	BUY	$85.91 - $100.83 $110,394 - $129,566	1,285 Added 7.87%	17,604 $1.54 Million
Q2 2020 Jul 20, 2020	BUY	$73.37 - $98.18 $332,292 - $444,657	4,529 Added 38.41%	16,319 $1.6 Million
Q1 2020 Apr 27, 2020	BUY	$64.5 - $97.79 $220,332 - $334,050	3,416 Added 40.79%	11,790 $901,000
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $32,314 - $40,432	448 Added 5.65%	8,374 $741,000
Q3 2019 Nov 08, 2019	SELL	$62.98 - $75.72 $121,614 - $146,215	-1,931 Reduced 19.59%	7,926 $605,000
Q2 2019 Aug 06, 2019	SELL	$65.7 - $83.98 $85,081 - $108,754	-1,295 Reduced 11.61%	9,857 $715,000
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $16,739 - $19,701	217 Added 1.98%	11,152 $900,000
Q4 2018 Feb 15, 2019	BUY	$77.85 - $96.01 $851,289 - $1.05 Million	10,935 New	10,935 $1.01 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Western Wealth Management, LLC with notifications on news.

Account

Western Wealth Management, LLC Abb Vie Inc. Transaction History